BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 22532676)

  • 21. Activated Nrf2 Interacts with Kaposi's Sarcoma-Associated Herpesvirus Latency Protein LANA-1 and Host Protein KAP1 To Mediate Global Lytic Gene Repression.
    Gjyshi O; Roy A; Dutta S; Veettil MV; Dutta D; Chandran B
    J Virol; 2015 Aug; 89(15):7874-92. PubMed ID: 25995248
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impaired CTL recognition of cells latently infected with Kaposi's sarcoma-associated herpes virus.
    Brander C; Suscovich T; Lee Y; Nguyen PT; O'Connor P; Seebach J; Jones NG; van Gorder M; Walker BD; Scadden DT
    J Immunol; 2000 Aug; 165(4):2077-83. PubMed ID: 10925292
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen interacts with multifunctional angiogenin to utilize its antiapoptotic functions.
    Paudel N; Sadagopan S; Chakraborty S; Sarek G; Ojala PM; Chandran B
    J Virol; 2012 Jun; 86(11):5974-91. PubMed ID: 22438557
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kaposi's sarcoma-associated herpesvirus-induced angiogenin plays roles in latency via the phospholipase C gamma pathway: blocking angiogenin inhibits latent gene expression and induces the lytic cycle.
    Sadagopan S; Valiya Veettil M; Paudel N; Bottero V; Chandran B
    J Virol; 2011 Mar; 85(6):2666-85. PubMed ID: 21209106
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of IFN-gamma-induced class II transactivator expression by a 19-kDa lipoprotein from Mycobacterium tuberculosis: a potential mechanism for immune evasion.
    Pai RK; Convery M; Hamilton TA; Boom WH; Harding CV
    J Immunol; 2003 Jul; 171(1):175-84. PubMed ID: 12816996
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interferon (IFN) beta acts downstream of IFN-gamma-induced class II transactivator messenger RNA accumulation to block major histocompatibility complex class II gene expression and requires the 48-kD DNA-binding protein, ISGF3-gamma.
    Lu HT; Riley JL; Babcock GT; Huston M; Stark GR; Boss JM; Ransohoff RM
    J Exp Med; 1995 Nov; 182(5):1517-25. PubMed ID: 7595221
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kaposi's sarcoma herpesvirus-induced endothelial cell reprogramming supports viral persistence and contributes to Kaposi's sarcoma tumorigenesis.
    Gramolelli S; Ojala PM
    Curr Opin Virol; 2017 Oct; 26():156-162. PubMed ID: 29031103
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The gammaherpesviruses Kaposi's sarcoma-associated herpesvirus and murine gammaherpesvirus 68 modulate the Toll-like receptor-induced proinflammatory cytokine response.
    Bussey KA; Reimer E; Todt H; Denker B; Gallo A; Konrad A; Ottinger M; Adler H; Stürzl M; Brune W; Brinkmann MM
    J Virol; 2014 Aug; 88(16):9245-59. PubMed ID: 24899179
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IFN-gamma regulation of class II transactivator promoter IV in macrophages and microglia: involvement of the suppressors of cytokine signaling-1 protein.
    O'Keefe GM; Nguyen VT; Ping Tang LL; Benveniste EN
    J Immunol; 2001 Feb; 166(4):2260-9. PubMed ID: 11160280
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Guanylate-Binding Protein 1 Inhibits Nuclear Delivery of Kaposi's Sarcoma-Associated Herpesvirus Virions by Disrupting Formation of Actin Filament.
    Zou Z; Meng Z; Ma C; Liang D; Sun R; Lan K
    J Virol; 2017 Aug; 91(16):. PubMed ID: 28592529
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thyrotropin-mediated repression of class II trans-activator expression in thyroid cells: involvement of STAT3 and suppressor of cytokine signaling.
    Kim H; Suh JM; Hwang ES; Kim DW; Chung HK; Song JH; Hwang JH; Park KC; Ro HK; Jo EK; Chang JS; Lee TH; Lee MS; Kohn LD; Shong M
    J Immunol; 2003 Jul; 171(2):616-27. PubMed ID: 12847226
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nuclear Localization and Cleavage of STAT6 Is Induced by Kaposi's Sarcoma-Associated Herpesvirus for Viral Latency.
    Wang C; Zhu C; Wei F; Gao S; Zhang L; Li Y; Feng Y; Tong Y; Xu J; Wang B; Yuan Z; Robertson ES; Cai Q
    PLoS Pathog; 2017 Jan; 13(1):e1006124. PubMed ID: 28099521
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nuclear Innate Immune DNA Sensor IFI16 Is Degraded during Lytic Reactivation of Kaposi's Sarcoma-Associated Herpesvirus (KSHV): Role of IFI16 in Maintenance of KSHV Latency.
    Roy A; Dutta D; Iqbal J; Pisano G; Gjyshi O; Ansari MA; Kumar B; Chandran B
    J Virol; 2016 Oct; 90(19):8822-41. PubMed ID: 27466416
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human Cytomegalovirus Decreases Major Histocompatibility Complex Class II by Regulating Class II Transactivator Transcript Levels in a Myeloid Cell Line.
    Sandhu PK; Buchkovich NJ
    J Virol; 2020 Mar; 94(7):. PubMed ID: 31915281
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kaposi's sarcoma-associated herpesvirus downregulates transforming growth factor β2 to promote enhanced stability of capillary-like tube formation.
    DiMaio TA; Gutierrez KD; Lagunoff M
    J Virol; 2014 Dec; 88(24):14301-9. PubMed ID: 25275137
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kaposi's sarcoma-associated herpesvirus viremia is associated with the progression of classic and endemic Kaposi's sarcoma.
    Pellet C; Kerob D; Dupuy A; Carmagnat MV; Mourah S; Podgorniak MP; Toledano C; Morel P; Vérola O; Dosquet C; Hamel Y; Calvo F; Rabian C; Lebbé C
    J Invest Dermatol; 2006 Mar; 126(3):621-7. PubMed ID: 16410791
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RIG-I Detects Kaposi's Sarcoma-Associated Herpesvirus Transcripts in a RNA Polymerase III-Independent Manner.
    Zhang Y; Dittmer DP; Mieczkowski PA; Host KM; Fusco WG; Duncan JA; Damania B
    mBio; 2018 Jul; 9(4):. PubMed ID: 29970461
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inactivation of class II transactivator by DNA methylation and histone deacetylation associated with absence of HLA-DR induction by interferon-gamma in haematopoietic tumour cells.
    Morimoto Y; Toyota M; Satoh A; Murai M; Mita H; Suzuki H; Takamura Y; Ikeda H; Ishida T; Sato N; Tokino T; Imai K
    Br J Cancer; 2004 Feb; 90(4):844-52. PubMed ID: 14970863
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Latent Kaposi's sarcoma-associated herpesvirus infection of endothelial cells activates hypoxia-induced factors.
    Carroll PA; Kenerson HL; Yeung RS; Lagunoff M
    J Virol; 2006 Nov; 80(21):10802-12. PubMed ID: 16956952
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HIV-1 Vpr Inhibits Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication by Inducing MicroRNA miR-942-5p and Activating NF-κB Signaling.
    Yan Q; Shen C; Qin J; Li W; Hu M; Lu H; Qin D; Zhu J; Gao SJ; Lu C
    J Virol; 2016 Oct; 90(19):8739-53. PubMed ID: 27440900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.